Physician profile
Samir Sharma
NPI 1043233554
$5,614.55
in general payments reported to CMS, 2019-2025
18 companies · $1,653 in 2025
The $1,653 reported for 2025 was more than what 78% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $173 · 2020: $225 · 2021: $281 · 2022: $45.49 · 2023: $52.13 · 2024: $3,185 · 2025: $1,653.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,822 · Food and Beverage: $2,053 · Gift: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,821.73 |
| Food and Beverage | $2,053.36 |
| Gift | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zavation Medical Products, LLC | $2,429.75 | 2024-2025 | |
| Genesys Orthopedics Systems, L.L.C. | $1,527.00 | 2024 | Sacroiliac Joint Fusion System |
| Abbott Laboratories | $401.57 | 2019-2021 | |
| Boston Scientific Corporation | $354.71 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Saluda Medical Americas, INC. | $177.04 | 2025 | Evoke |
| Nevro Corp. | $165.36 | 2024 | Senza |
| Globus Medical, INC. | $80.11 | 2025 | Senza |
| Collegium Pharmaceutical, INC. | $76.62 | 2019-2024 | Belbuca |
| Abbvie INC. | $75.90 | 2021-2024 | Ubrelvy |
| Biotronik Nro, INC. | $63.96 | 2025 | Prospera |
| Horizon Therapeutics Plc | $48.93 | 2020-2021 | |
| Allergan, INC. | $46.36 | 2019-2020 | |
| Pacira Therapeutics, INC. | $38.57 | 2019 | |
| Scilex Pharmaceuticals INC. | $35.34 | 2019-2024 | |
| Siemens Medical Solutions USA, INC. | $31.87 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $23.11 | 2023 | Intellis Adaptivestim |
| Redhill Biopharma INC. | $20.45 | 2020 | |
| Ibsa Pharma INC. | $17.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samir Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.